CorMedix (CRMD)
Sells an FDA-approved catheter lock solution and a portfolio of hospital anti-infective drugs across the US.
$8.54
Pre-market−0.08 (−0.87%)
At close$8.62(+2.80%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.10
Revenue estimate
$53.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.22$0.30$0.28$0.57$0.61$0.43$0.29Pending
Estimate$0.17$0.25$0.20$0.48$0.86$0.35$0.24−$0.10
Surprise+29.4%+20.0%+40.0%+18.7%−29.1%+22.9%+21.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$31.2M$39.1M$39.7M$104.3M$128.6M$127.4M$101.9MPending
Estimate$31.3M$29.9M$42.5M$127.0M$127.0M$105.0M$96.0M$53.3M
Surprise−0.2%+30.8%−6.4%−17.9%+1.3%+21.4%+6.1%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.10 | — | — |
| Aug 2026 | $0.24 | $0.29 | +21.8% |
| May 2026 | $0.35 | $0.43 | +22.9% |
| Mar 2026 | $0.86 | $0.61 | −29.1% |
| Nov 2025 | $0.48 | $0.57 | +18.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.10 | — | — | $53.3M | — | — | — |
| Aug 13, 2026 | $0.24 | $0.29 | +21.8% | $96.0M | $101.9M | +6.1% | +14.7% |
| May 14, 2026 | $0.35 | $0.43 | +22.9% | $105.0M | $127.4M | +21.4% | −4.8% |
| Mar 5, 2026 | $0.86 | $0.61 | −29.1% | $127.0M | $128.6M | +1.3% | +2.5% |
| Nov 12, 2025 | $0.48 | $0.57 | +18.7% | $127.0M | $104.3M | −17.9% | −1.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 14, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 19, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 5, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 16, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 6, 2015 | |||||||